NO975295L - 6-Karbamido-dihydropyran-derivater - Google Patents
6-Karbamido-dihydropyran-derivaterInfo
- Publication number
- NO975295L NO975295L NO975295A NO975295A NO975295L NO 975295 L NO975295 L NO 975295L NO 975295 A NO975295 A NO 975295A NO 975295 A NO975295 A NO 975295A NO 975295 L NO975295 L NO 975295L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- optionally substituted
- cycloalkyl
- substituted aryl
- aryl
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 125000003107 substituted aryl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 101100440695 Dictyostelium discoideum corB gene Proteins 0.000 abstract 1
- 150000008575 L-amino acids Chemical class 0.000 abstract 1
- 101150020251 NR13 gene Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- -1 amino, hydroxy Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 239000002911 sialidase inhibitor Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9510141.6A GB9510141D0 (en) | 1995-05-19 | 1995-05-19 | Chemical compounds |
| GBGB9525389.4A GB9525389D0 (en) | 1995-12-12 | 1995-12-12 | Chemical compounds |
| PCT/AU1996/000289 WO1996036628A1 (en) | 1995-05-19 | 1996-05-13 | 6-carboxamido dihydropyran derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975295D0 NO975295D0 (no) | 1997-11-18 |
| NO975295L true NO975295L (no) | 1997-11-18 |
Family
ID=26307051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975295A NO975295L (no) | 1995-05-19 | 1997-11-18 | 6-Karbamido-dihydropyran-derivater |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5990156A (de) |
| EP (1) | EP0833825B1 (de) |
| JP (1) | JP4162712B2 (de) |
| KR (1) | KR19990014910A (de) |
| CN (1) | CN1184473A (de) |
| AT (1) | ATE206116T1 (de) |
| AU (1) | AU709127B2 (de) |
| CA (1) | CA2220754A1 (de) |
| CZ (1) | CZ366697A3 (de) |
| DE (1) | DE69615555T2 (de) |
| ES (1) | ES2164881T3 (de) |
| HU (1) | HUP9801766A3 (de) |
| NO (1) | NO975295L (de) |
| PL (1) | PL323471A1 (de) |
| WO (1) | WO1996036628A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100409844C (zh) * | 1995-02-27 | 2008-08-13 | 吉里德科学公司 | 神经氨酸苷酶抑制剂 |
| US5866601A (en) * | 1995-02-27 | 1999-02-02 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US5859284A (en) * | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US6518438B2 (en) | 1996-08-23 | 2003-02-11 | Gilead Sciences, Inc. | Preparation of cyclohexene carboxylate derivatives |
| US5994377A (en) * | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
| US5886213A (en) * | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US20040053999A1 (en) * | 1997-09-17 | 2004-03-18 | Bischofberger Norbert W. | Novel compounds and methods for synthesis and therapy |
| TW477783B (en) * | 1997-12-12 | 2002-03-01 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
| DK1040094T3 (da) * | 1997-12-17 | 2009-06-02 | Biocryst Pharm Inc | Substitueret cyklopentan og cyklopenten-forbindelser anvendelige som neuraminidase-inhibitorer |
| US6455571B1 (en) | 1998-04-23 | 2002-09-24 | Abbott Laboratories | Inhibitors of neuraminidases |
| US6518305B1 (en) | 1998-04-23 | 2003-02-11 | Abbott Laboratories | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| US6593314B1 (en) | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
| US7045535B2 (en) * | 2001-03-08 | 2006-05-16 | Biocryst Pharmaceuticals, Inc. | Compounds useful for inhibiting paramyxovirus neuraminidase |
| WO2002092555A1 (en) * | 2001-05-11 | 2002-11-21 | Sankyo Company, Limited | Sialic acid derivatives |
| WO2010127443A1 (en) * | 2009-05-04 | 2010-11-11 | National Research Council Of Canada | Inhibitors of sialidase or sialidase-like enzymes |
| CN115991702B (zh) * | 2021-12-09 | 2024-02-02 | 珠海市藤栢医药有限公司 | 芳基c-葡萄糖苷衍生物、其制备方法及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP249A (en) * | 1990-04-24 | 1993-03-17 | Biota Scient Management Pty Ltd | Anti-viral compounds. |
| DE4131311A1 (de) * | 1991-09-20 | 1993-04-01 | Basf Ag | Dihydropyranderivate und diese enthaltende pflanzenschutzmittel |
| AU659501B2 (en) * | 1991-10-23 | 1995-05-18 | Biota Scientific Management Pty Ltd | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid |
| FR2687674B1 (fr) * | 1992-02-07 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
-
1996
- 1996-05-13 HU HU9801766A patent/HUP9801766A3/hu unknown
- 1996-05-13 WO PCT/AU1996/000289 patent/WO1996036628A1/en not_active Ceased
- 1996-05-13 ES ES96911872T patent/ES2164881T3/es not_active Expired - Lifetime
- 1996-05-13 JP JP53439196A patent/JP4162712B2/ja not_active Expired - Fee Related
- 1996-05-13 AU AU54932/96A patent/AU709127B2/en not_active Ceased
- 1996-05-13 CN CN96194026A patent/CN1184473A/zh active Pending
- 1996-05-13 CA CA002220754A patent/CA2220754A1/en not_active Abandoned
- 1996-05-13 EP EP96911872A patent/EP0833825B1/de not_active Expired - Lifetime
- 1996-05-13 KR KR1019970708256A patent/KR19990014910A/ko not_active Withdrawn
- 1996-05-13 CZ CZ973666A patent/CZ366697A3/cs unknown
- 1996-05-13 US US08/945,676 patent/US5990156A/en not_active Expired - Lifetime
- 1996-05-13 AT AT96911872T patent/ATE206116T1/de not_active IP Right Cessation
- 1996-05-13 DE DE69615555T patent/DE69615555T2/de not_active Expired - Fee Related
- 1996-05-13 PL PL96323471A patent/PL323471A1/xx unknown
-
1997
- 1997-11-18 NO NO975295A patent/NO975295L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2164881T3 (es) | 2002-03-01 |
| EP0833825A4 (de) | 1998-10-07 |
| CN1184473A (zh) | 1998-06-10 |
| HUP9801766A3 (en) | 2000-09-28 |
| WO1996036628A1 (en) | 1996-11-21 |
| JPH11505227A (ja) | 1999-05-18 |
| AU5493296A (en) | 1996-11-29 |
| NO975295D0 (no) | 1997-11-18 |
| EP0833825B1 (de) | 2001-09-26 |
| CA2220754A1 (en) | 1996-11-21 |
| JP4162712B2 (ja) | 2008-10-08 |
| DE69615555D1 (de) | 2001-10-31 |
| CZ366697A3 (cs) | 1998-04-15 |
| US5990156A (en) | 1999-11-23 |
| PL323471A1 (en) | 1998-03-30 |
| EP0833825A1 (de) | 1998-04-08 |
| KR19990014910A (ko) | 1999-02-25 |
| HUP9801766A2 (hu) | 2000-06-28 |
| DE69615555T2 (de) | 2002-05-29 |
| AU709127B2 (en) | 1999-08-19 |
| ATE206116T1 (de) | 2001-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO975295L (no) | 6-Karbamido-dihydropyran-derivater | |
| NO992336L (no) | Raf-kinase-inhibitorer | |
| NZ505675A (en) | N-alkylamide substituted hydroxamic acid derivatives are used as antibacterial agents | |
| CO5150227A1 (es) | Compuestos de triazol y su utilizacion | |
| EA200000990A1 (ru) | Вич-ингибирующие производные пиримидина | |
| BG93979A (bg) | Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им | |
| EP2308844A3 (de) | Caspase inhibitoren und ihre verwendung | |
| AR039226A2 (es) | Compuestos utiles como intermediarios de preparacion y procedimientos | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| DE60014393D1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| CY1109085T1 (el) | Νεα αλατα | |
| HUP0102099A2 (hu) | Szubsztituált 2-oxo-alkánsav-[2-(indol-3-il)-etil]-amid-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| SE7704783L (sv) | Medel for separationsendamal och forfarande for dess framstellning | |
| CY1105780T1 (el) | Ετepο-δικυκλικοi crf ανταγωνιστeς | |
| ES8801808A1 (es) | Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona | |
| DE69903040D1 (de) | Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus | |
| DE69714056D1 (de) | Cytostatische hydroxamsäurederivate | |
| EA200602136A1 (ru) | Комбинации замещенных 1-фенил-1,5-дигидропиридо[3,2-b] индол-2-онов и других ингибиторов вич | |
| HUP0201797A2 (hu) | 3-Amino-2-benzil-1-fenil-propán-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| ATE397609T1 (de) | Corticotropinfreisetzungsfaktor antagonisten | |
| AR044786A1 (es) | Derivados de 2- aminobenzoilo | |
| DE69217717D1 (de) | Benzopyranderivate und Verfahren zu deren Herstellung | |
| CY1106212T1 (el) | Χρηση παραγωγων θειαζολης δια την παρασκευη ενος φαρμακου για την προστασια των μιτοχονδριων | |
| EA200100677A1 (ru) | Производные 6-азаурацила, ингибирующие il-5 | |
| EA200200379A3 (ru) | Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |